188Re-HYNIC-trastuzumab enhances the effect of apoptosis induced by trastuzumab in HER2-overexpressing breast cancer cells

Introduction

(2009) Benjamin O. Anderson et al.   CANCER

In vivo examination of 188Re(I)-tricarbonyl-labeled trastuzumab to target HER2-overexpressing breast cancer

(2009) Kuo-Ting Chen et al.   NUCLEAR MEDICINE AND BIOLOGY

Evaluating the potential of 188Re-SOCTA–trastuzumab as a new radioimmunoagent for breast cancer treatment

(2009) Tsai-Yueh Luo et al.   NUCLEAR MEDICINE AND BIOLOGY

Iodine-131 Induces Mitotic Catastrophes and Activates Apoptotic Pathways in HeLa Hep2 Cells

(2008) David Eriksson et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Tumor resistance to apoptosis

(2008) Simone Fulda   INTERNATIONAL JOURNAL OF CANCER

Trastuzumab treatment in patients with advanced or recurrent endometrial carcinoma overexpressing HER2/neu

(2008) Alessandro D. Santin et al.   INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS

Trastuzumab-Resistant Breast Cancer Cells Remain Sensitive to the Auger Electron-Emitting Radiotherapeutic Agent 111In-NLS-Trastuzumab and Are Radiosensitized by Methotrexate

(2008) D. L. Costantini et al.   JOURNAL OF NUCLEAR MEDICINE

Breast Cancer Issues in Developing Countries: An Overview of the Breast Health Global Initiative

(2008) Benjamin O. Anderson et al.   WORLD JOURNAL OF SURGERY